1. Aghajanian C, Soignet S, Dizon D S, Pien C S, Adams J, Elliott P J, Sabbatini P, Miller V, Hensley M L, Pezzulli S, Canales C, Daud A and Spriggs D R 2002 A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies; Clin. Cancer Res. 8 2505–2511
2. Agrawal N, Pallos J, Slepko N, Apostol B L, Bodai L, Chang L-W, Chiang A-S, Thompson L M and Marsh J L 2005 Identification of combinatorial drug regimens for treatment of Huntington’s disease using Drosophila; Proc. Natl. Acad. Sci. USA 102 3777–3781
3. Ali A, Bharadwaj S, O’Carroll R and Ovsenek N 1998 HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes; Mol. Cell. Biol. 18 4949–4960
4. An, W G, Schulte, T W and Neckers, L M 2000 The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome; Cell Growth Differ. 11 355–360
5. Auluck P K and Bonini, N M. 2002b Pharmacological prevention of Parkinson disease in Drosophila; Nat. Med. 8 1185–1186